$3.46
0.030.84%
Pre-Market: 4:27 PM EDT
15 minutes delayed
Comments
Loading...
Macrogenics (NASDAQ:MGNX) Stock Quotes, Forecast and News Summary
Macrogenics Stock (NASDAQ: MGNX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Macrogenics (MGNX) stock?
You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.
Who are Macrogenics (MGNX) competitors?
Other companies in Macrogenics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Atossa Therapeutics (NASDAQ:ATOS) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the forecast, or price target, for Macrogenics (MGNX) stock?
Macrogenics has a consensus price target of $12.00.
What is the current price for Macrogenics (MGNX)?
The stock price for Macrogenics (NASDAQ: MGNX) is $3.4588 last updated October 1, 2024 at 4:27 PM EDT.
Does Macrogenics (MGNX) pay a dividend?
There are no upcoming dividends for Macrogenics.
When is Macrogenics (NASDAQ:MGNX) reporting earnings?
Macrogenics’s Q3 earnings are confirmed for Monday, November 4, 2024.
Is Macrogenics (MGNX) going to split?
There is no upcoming split for Macrogenics.
What sector and industry does Macrogenics (MGNX) operate in?
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.